AnquinetLRietjensJvan der HeideA. (2014) Physicians’ experiences and perspectives regarding the use of continuous sedation until death for cancer patients in the context of psychological and existential suffering at the end of life. Psychooncology23: 539–546.
2.
ArrietaOAnguloLPNunez-ValenciaC. (2013) Association of depression and anxiety on quality of life, treatment adherence, and prognosis in patients with advanced non-small cell lung cancer. Ann Surg Oncol20: 1941–1948.
3.
BreitbartWRosenfeldBGibsonC. (2010) Meaning-centered group psychotherapy for patients with advanced cancer: a pilot randomized controlled trial. Psychooncology19: 21–28.
4.
BrownKWLevyARRosbergerZ. (2003) Psychological distress and cancer survival: a follow-up 10 years after diagnosis. Psychosom Med65: 636–643.
5.
ChochinovHMKristjansonLJBreitbartW. (2011) Effect of dignity therapy on distress and end-of-life experience in terminally ill patients. Lancet Oncol12: 753–762.
6.
FallerHSchulerM. (2013) Effects of psycho-oncology interventions on emotional distress and quality of life in adult patients with cancer: systematic review and meta-analysis. J Clin Oncol31: 782–793.
7.
GanziniLGoyERDobschaSK (2008) Why Oregon patients request assisted death: family members’ views. J Gen Intern Med23: 154–157.
8.
GrassiLCarusoRHammelefK. (2014) Efficacy and safety of pharmacotherapy in cancer-related psychiatric disorders across the trajectory of cancer care: a review. Int Rev Psychiatry26: 44–62.
9.
GriffithsRJohnsonMWCarducciMA. (2016) Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: a randomized double-blind trial. J Psychopharmacol30: 1181-1197.
10.
GrobCSDanforthALChopraGS. (2011) Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. Arch Gen Psychiatry68: 71–78.
11.
GrofSGoodmanLERichardsWA. (1973) LSD-assisted psychotherapy in patients with terminal cancer. Int Pharmacopsychiatry8: 129–144.
12.
JaiswalRAliciYBreitbartW (2014) A comprehensive review of palliative care in patients with cancer. Int Rev Psychiatry26: 87–101.
13.
KesslerRCAguilar-GaxiolaSAlonsoJ. (2009) The global burden of mental disorders: an update from the WHO World Mental Health (WMH) surveys. Epidemiol Psichiatr Soc18: 23–33.
14.
KesslerRCChiuWTDemlerO. (2005) Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry62: 617–627.
15.
MitchellAJChanMBhattiH. (2011) Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol12: 160–174.
16.
RobinsonSKissaneDWBorrkerJ. (2016) A review of the construct of demoralization: history, definitions, and future directions for palliative care. Am J Hosp Palliat Care33: 93–101.
17.
RossSBossisAGussJ. (2016) Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial. J Psychopharmacol30: 1165-1180.
